Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Warning Letters
Manufacturing
FDA slams Indian drugmaker Unexo with warning letter
Unexo Life Sciences, an Indian drugmaker that manufactures a medicated patch for pain relief, has been hit with a warning letter from the FDA.
Joseph Keenan
Nov 20, 2024 9:25am
FDA scrutinizes Novo on production issues at semaglutide plant
Oct 31, 2024 9:33am
FDA issues Form 483s to Japanese, Indian drugmakers
Sep 10, 2024 8:50am
EyePoint's Yutiq production lands in the FDA's crosshairs
Aug 27, 2024 4:07pm
FDA rebukes troubled Eugia production site with a warning letter
Aug 19, 2024 8:10am
CDMO Brassica blasted in 4-observation FDA warning letter
Jul 24, 2024 9:25am